Phase II trial of ICRF-187 in non-small cell lung cancer.
D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000187:drug effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D010976:Platelet Count; D011929:Razoxane / Q000627:therapeutic use* / Q000633:toxicity; D013237:Stereoisomerism
D010879:Piperazines; D011929:Razoxane